Biotech Industry

• 10/24/2024

  Palantir Technologies Soars 156%: Unlocking AI Software Gains

• 10/23/2024

  IBM’s Q3 Earnings: A Make-or-Break Moment for the Tech Giant

• 10/23/2024

  Why 80% of AI Projects Flop: Microsoft’s Hidden Weakness

• 10/23/2024

  FDA Breakthrough: Denifanstat Validated by Lancet Review and Designation

• 10/23/2024

  Netflix’s Profit Play: Is It a Buy?

• 10/23/2024

  Sangamo Therapeutics: From Struggle to Billion-Dollar Potential

• 10/23/2024

  GSK vs Moderna: The High-Stakes Patent Battle Shaping the Future of Vaccines

• 10/23/2024

  Surge in Semiconductor ETFs: What’s Behind the Boom

• 10/22/2024

  Intel Stock Surges on Potential Altera Stake Sale

• 10/22/2024

  Why Microsoft Stock Is a Hidden Bargain: 3 Key Reasons to Buy MSFT